Artiva Biotherapeutics (ARTV) Change in Acquisitions & Divestments (2023 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Change in Acquisitions & Divestments for 3 consecutive years, with $24.0 million as the latest value for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments rose 72.04% year-over-year to $24.0 million; the TTM value through Dec 2025 reached $110.9 million, up 96.76%, while the annual FY2025 figure was $110.9 million, 96.76% up from the prior year.
  • Change in Acquisitions & Divestments hit $24.0 million in Q4 2025 for Artiva Biotherapeutics, down from $29.6 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $29.6 million in Q3 2025 and bottomed at $12.0 million in Q3 2023.
  • Average Change in Acquisitions & Divestments over 3 years is $19.2 million, with a median of $15.0 million recorded in 2024.
  • Year-over-year, Change in Acquisitions & Divestments increased 3.33% in 2024 and then skyrocketed 138.9% in 2025.
  • Artiva Biotherapeutics' Change in Acquisitions & Divestments stood at $12.8 million in 2023, then rose by 8.98% to $14.0 million in 2024, then soared by 72.04% to $24.0 million in 2025.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $24.0 million, $29.6 million, and $28.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.